← Back to Search

Behavioural Intervention

DBT - Phase 1 and 2 for Suicide (CAMPUS-Feas Trial)

N/A
Waitlist Available
Led By Scott Compton, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up beginning to end of stage 2 (up to 8 weeks)
Awards & highlights

CAMPUS-Feas Trial Summary

CAMPUS - Feasibility Sub-Study

CAMPUS-Feas Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~beginning to end of stage 2 (up to 8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and beginning to end of stage 2 (up to 8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Counselor Assessment of Participant Study Satisfaction During Stage 1 of Treatment as Measured by the Client Satisfaction Questionnaire (CSQ)
Counselor Assessment of Participant Study Satisfaction During Stage 2 of Treatment as Measured by the Client Satisfaction Questionnaire (CSQ)
Counselor Recruitment
+7 more

CAMPUS-Feas Trial Design

8Treatment groups
Experimental Treatment
Active Control
Group I: TAU to MaintenanceExperimental Treatment1 Intervention
Subject assigned to TAU for Phase 1. Subject is a Phase 1 TAU Responder, thus placed into ongoing Maintenance/Monitoring.
Group II: TAU to DBTExperimental Treatment2 Interventions
Subject assigned to TAU for Phase 1. Subject is a Phase 1 TAU Insufficient Responder, then assigned to Phase 2 DBT.
Group III: TAU to CAMSExperimental Treatment2 Interventions
Subject assigned to TAU for Phase 1. Subject is a Phase 1 TAU Insufficient Responder, then assigned to Phase 2 CAMS.
Group IV: DBT OnlyExperimental Treatment1 Intervention
Subject Assigned to DBT for Phase 1, continuing up to 16 weeks.
Group V: CAMS to MaintenanceExperimental Treatment1 Intervention
Subject assigned to CAMS for Phase 1. Subject is a Phase 1 CAMS Responder, thus placed into ongoing Maintenance/Monitoring.
Group VI: CAMS to DBTExperimental Treatment2 Interventions
Subject assigned to CAMS for Phase 1. Subject is a Phase 1 CAMS Insufficient Responder, then assigned to Phase 2 DBT.
Group VII: CAMS to CAMSExperimental Treatment2 Interventions
Subject assigned to CAMS for Phase 1. Subject is a Phase 1 CAMS Insufficient Responder, then assigned to Phase 2 CAMS.
Group VIII: Study CounselorsActive Control1 Intervention
Consented Study Counselors from each of the 4 sites. Data collected regarding the Counselors is minimal and is maintained completely separately from the other 7 Student Participant Arms/Groups.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TAU - Phase 1
2021
N/A
~90
CAMS - Phase 1
2021
N/A
~90
DBT - Phase 1 and 2
2021
N/A
~90
CAMS - Phase 2
2021
N/A
~90
DBT - Phase 2
2021
N/A
~90

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,357 Previous Clinical Trials
3,418,986 Total Patients Enrolled
12 Trials studying Suicide
3,444 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,781 Previous Clinical Trials
2,674,894 Total Patients Enrolled
112 Trials studying Suicide
1,156,735 Patients Enrolled for Suicide
Scott Compton, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
700 Total Patients Enrolled
1 Trials studying Suicide
700 Patients Enrolled for Suicide

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CAMPUS - Feasibility Sub-Study
2021. "CAMPUS - Feasibility Sub-Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04728815.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top